Abstract
OBJECTIVE: Many agents have been studied to reduce the damaging effects of ischemia in the testis and subsequent reperfusion. There is evidence that rosuvastatin increases blood flow in the testis during ischemia and reperfusion as observed with color Doppler. In this study, it was aimed to determine whether rosuvastatin, in addition to increasing blood flow, also has beneficial biochemical and histopathological effects. MATERIAL and METHODS: In this study, 18 male rats of the Sprague-Dawley strain were used (3 groups were formed, each containing six subjects: Sham group, torsion-detorsion group, torsion-detorsion+rosuvastatin group). The ischemia duration was determined as 2 hours. Rosuvastatin was administered to the torsion-detorsion+rosuvastatin group 30 minutes before detorsion. Four hours after the surgical procedure, orchiectomy was performed, MDA levels were measured, and histopathological evaluation was conducted using Cosentino scoring. RESULTS: When evaluated using Cosentino scoring, a histopathologically significant difference was observed between the sham group and the torsion-detorsion group. A significant difference was observed between the torsion-detorsion group and the torsion-detorsion+rosuvastatin groups. However, in terms of MDA values, no statistically significant difference was found between the groups. CONCLUSION: Histopathologically, the improvement observed in the presence of rosuvastatin could not be demonstrated by MDA levels. It was concluded that studies in which long-term rosuvastatin administration is planned in the torsion+detorsion model would be beneficial. Keywords: ischemia, MDA (malondialdehyde), rosuvastatin, testicular torsion